|
Wednesday 12th October 2022 |
Text too small? |
Rua Bioscience (NZX: RUA ) advises that all resolutions put to its hybrid Annual Shareholders’ Meeting (held online and in Gisborne today) were passed by Shareholders.
Those resolutions being:
- That the Board be authorised to fix the auditor’s remuneration.
- That Trevor Burt be re-elected as a director of Rua.
- That Brett Gamble be re-elected as a director of Rua.
- That Teresa Ciprian be re-elected as a director of Rua.
The results of the voting poll are in the attached document.
Ends
For more information, please visit www.ruabio.com or contact:
Media
Kerry Donovan
Communications Manager
+64 (21) 128 7689
kerry.donovan@ruabio.com
Investors
Hamish White
Chief Financial Officer
+64 (21) 050 5795
Hamish.white@ruabio.com
Rua Bioscience Results of the 2022 Annual Shareholders' Meeting
No comments yet
RYM - Successful completion of full bank debt refinance
Curious about dividend investment strategies?
Kiwi Property delivering on FY26 strategic priorities
Genesis Approves Investment for Edgecumbe Solar Farm
November 24th Morning Report
General Capital Announces Further Strong Growth
Comvita announces key leadership appointments
OCA - Momentum Building on Stronger Foundations
Devon Funds Morning Note - 20 November 2025
ERD - Strong cash flow supports focused ANZ market expansion